Effect of inhibition of nitric oxide synthase on the vasopressor response to ephedrine

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 10, 2003, Pages 966-971

  Dabisch, Paul A ^a   Liles, John T ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Endothelial dysfunction; Ephedrine; L NAME; Nitric oxide

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; EPHEDRINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART INFARCTION; HEART OUTPUT; HEART RATE; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; STROKE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION; VASOSPASM;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DRUG INTERACTIONS; EPHEDRINE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PHENTOLAMINE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0347384217     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-100     Document Type: Article

References (45)

1. Aisaka K., Gross, S.S., Griffith, O.W., and Levi, R. 1989. L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivo. Biochem. Biophys. Res. Comm. 163: 710-717.
2. Bao, J.X., Wang, B., and Yang, Z.C. 1990. Effects of ephedrine on postsynaptic alpha-adrenoreceptors and presynaptic beta-adrenoreceptors in isolated guinea pig portal veins. Zhongguo Yaoli Xuebao, 11: 130-133.
3. Barton, M, Haudenschild, C.C., Duscio, L.V., Shaw, S., Minter, K., and Luscher, T.F. 1998. Endothrlin ETA receptor blockade restores no-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95: 14367-14372.
4. T-nitro-L-arginine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats. Am. J. Physiol. 260: 1025-1029.
5. Boulanger, C.M., and Luscher, T.F. 1990 Release of endothelin from the porcine aorta. J. Clin. Invest. 85: 587-590.
6. Brock, R.W., Tschakovsky, M.E., Shoemaker, J.K., Halliwill, J.R., Joyner, M.J., and Hughson RL. 1998. Effects of acetylcholine and nitric oxide on forearm blood flow at rest and after a single muscle contraction. J. Appl. Physiol. 85: 2249-2254.
7. Champion, H.C., and Kadowitz, P.J. 1999. Vasodepressoi responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the rat. Vasodepressor responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the rat. J. Cardiovasc. Pharmacol. 33: 280-284.
8. Champion, H.C., Czapla, M.A., and Kadowitz, P.J. 1998 Responses to angiotensin peptides are mediated by AT1 receptors in the rat. Am. J. Physiol. 274: 115-123.
9. Champion, H.C., Bivalacqua, T.J., D'Souza, F.M., Ortiz, L.A., Jeter, J.R., Toyoda, K., Heistad, D.D., Hyman, A.L., and Kadowitz, P.J. 1999. Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. Circ. Res. 84: 1422-1432.
10. Champion, H.C., Bivalacqua, T.J., Zadina, J.E., Kastin, A.J., Hyman, A.L., Kadowitz, P.J. 2002. Role of nitric oxide in mediating vasodilator responses to opioid peptides in the rat. Clin. Exp. Pharmacol. Physiol. 29: 229-232.
11. Cockings, J.G.L., and Brown, M.A. 1997. Ephedrine abuse causing acute myocardial infarction. Med. J. Aust. 167: 199-200.
12. Dedkova, E.N., Wang, Y.G., Blatter, L.A., and Lipsius, S.L. 2002. Nitric oxide signaling by selective beta(2)-adrenoreceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes. J. Physiol. 542: 711-723.
13. Drexler, H., and Hornig, B. 1999. Endothelial dysfunction in human disease. J. Mol. Cell Cardiol. 31: 51-60.
14. Ferro, C.J., and Webb, D.J. 1997. Endothelial dysfunction and hypertension. Drugs, 53(Suppl. 1): 30-41.
15. Furchgott, R.F., and Zawadzki, J.V. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288: 373-376.
16. Haller, C.A., and Benowitz, N.L. 2000. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. New Engl. J. Med. 343: 1833-1887.
17. Hoffman, B.B., and Lefkowitz, R.J. 1996. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In The pharmacological basis of therapeutics. Edited by J.E. Hardman and L.E. Limbird. McGraw Hill, New York, NY, U.S.A. p. 221.
18. Hornig, B., Arakawa, N., and Drexler, H. 1998. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. Eur. Heart J. 19: G48-G53.
19. Jancso, T., Rabloczky, G., and Csukas, M. 1972. Examination of the law of initial value in connection with the blood pressure response of anaesthetized and non-anaesthetized cats. Acta Physiol. Acad. Sci. Hung. 42: 333-343.
20. Jordan, J., Tank, J., Stoffels, M., Franke, G., Christensen, N.J., Luft, F.C., and Boschmann, M. 2001. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J. Clin. Endocrinol. Metab. 86: 2803-2810.
21. Josefson, D. 1996. Herbal stimulant causes U.S. deaths. Br. Med. J. 312: 1441.
22. Kakoki, M., Zou, A., and Mattson, D.L. 2001. The influence of nitric oxide synthase 1 on blood flow and interstitial nitric oxide in the kidney. Am. J. Physiol. 281: 91-97.
23. Kawasuji, T., Koike, K., and Saito, H. 1996. Chronotropic effects of optical isomers of ephedrine and methylephedrine in the isolated rat right atria and in vitro assessment of direct and indirect actions on beta 1-adrenoreceptors. Biol. Pharm. Bull. 19: 1423-1428.
24. Kissling, G. Ross, C., and Brandle, M. 1993. Validity of thermal dilution technique for measurement of cardiac output in rats. Am. J. Physiol. 265: 1007-1013.
25. Lambrecht, J.E., Hamilton, W, and Rabinovich A. 2000. A review of herb-drug interactions: documented and theoretical. U.S. Pharmacist [serial online], 25(8): 42-53. Available from: http://www.uspharmacist.com/oldformat. asp?url = newlook/ files/comp/aug00alt.htm.
26. Li, P., Chuanyo, T., and Eisenach, J.C. 1996. Pregnancy and ephedrine increase the release of nitric oxide in ovine uterine arteries. Anesth. Analg. 82: 288-293.
27. Lopez-Jaramillo, P., and Casas, J.P. 2002. Blockade of endothelial enzymes: new therapeutic targets. J. Hum. Hypertens. 16: S100-S103.
28. w-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J. Appl. Physiol. 71: 2026-2031.
29. Onuigbo, M, and Alikhan, M. 1998. Over-the-counter sympathomimetics: a risk factor for cardiac arrhythmias in pregnancy. South. Med. J. 91: 1153-1155.
30. Panza, J.A., Casino, P.R., Kilcoyne, C.M., and Quyyumi, A.A. 1994. Impaired endothelial dependent vasodilation in people with essential hypertension: evidence that the abnormality is not at the muscarinic level. J. Am. Coll. Cardiol. 23: 1610-1616.
31. Parkington, H.C., Chow, J.M., Evans, R.G., Coleman, H.A., and Tare, M. 2002. Role for endothelium-derived hyperpolarizing factor in vascular tone in rat mesenteric and hindlimb circulations in vivo. J. Physiol. 542: 929-937.
32. Pradhan, L., Dabisch, P.A., Liles, J.T., Agrawal, K.C., and Kadowitz, P.J. 2003. Effect of acute intravenous cocaine administration on endothelium-dependent vasodepressor responses to acetylcholine. J. Cardiovasc. Pharmacol. Ther. 8: 43-51.
33. Rees, D.D., Palmer, R.M.J., Schulz, R., Hodson, H.F., and Moncada, S. 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746-752.
34. Rees, D.D., Palmer, R.M.J., and Moncada, S. 1999. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86: 3375-3378.
35. Rezkalla, S.H., Mesa, J., Sharma, P., and Kloner, R.A. 2002. Myocardial infarction temporarily related to ephedra- a possible role for the coronary microcirculation. W.M.J. 101: 64-66.
36. Roks, A.J. 2002. Ikprovement of endothelial-derived hyperpolarizing factor function by RAS inhibition. J. Hypertens. 20: 363-365.
37. Ross, G., Chaudhuri, G., Ignarro, L.J., and Chyu, K.Y. 1991. Acetylcholine vasodilation of resistance vessels in vivo may not entirely depend on newly synthesized nitric oxide. Eur. J. Pharmacol. 195: 291-293.
38. Sander, M., Chavoshan, B., and Victor, R.G. 1999. A large blood pressure raising effect of nitric oxide synthase inhibition in humans. Hypertension, 33: 937-942.
39. Theoharides, T.C. 1997. Sudden death of a healthy college student related to ephedrine toxicity from a ma-huang-containing drink. J. Clin. Psychopharmacol. 17(5): 437-438.
40. Vansal, S.S, and Feller, D.R. 1999. Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem. Pharmacol. 58: 807-810.
41. Waldeck, B., and Widmark, E. 1985. The interaction of ephedrine with beta-adrenoreceptors in tracheal, cardiac, and skeletal muscles. Clin. Exp. Pharmacol. Physiol. 12: 439-442.
42. + current in cat atrial myocytes. J. Gen. Physiol. 119: 69-82.
43. Whittle, B.J.R., Lopez-Belmonte, J., and Rees, D.D. 1989. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P, and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 98: 646-652.
44. Young, R., and Glennon, R.A. 1998. Discriminative stimulus properties of (-)ephedrine. Pharmacol. Biochem. Behav. 60: 771-775.
45. Zahn, K.A., Li, R.L., and Purssell RA. 1999. Cardiovascular toxicity after ingestion of "herbal ecstasy". J. Emerg. Med. 17: 289-291.